 Brain Neoplasms
"Brain Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Descriptor ID |
D001932
|
| MeSH Number(s) |
C04.588.614.250.195 C10.228.140.211 C10.551.240.250
|
| Concept/Terms |
Brain Neoplasms- Brain Neoplasms
- Neoplasms, Brain
- Brain Neoplasm
- Neoplasm, Brain
- Brain Tumors
- Brain Tumor
- Tumor, Brain
- Tumors, Brain
Brain Cancer- Brain Cancer
- Brain Cancers
- Cancer, Brain
- Cancers, Brain
- Malignant Neoplasms, Brain
- Brain Malignant Neoplasm
- Brain Malignant Neoplasms
- Malignant Neoplasm, Brain
- Cancer of Brain
- Cancer of the Brain
- Neoplasms, Brain, Malignant
- Brain Neoplasms, Malignant
- Brain Neoplasm, Malignant
- Malignant Brain Neoplasm
- Malignant Brain Neoplasms
Brain Tumor, Recurrent- Brain Tumor, Recurrent
- Brain Tumors, Recurrent
- Recurrent Brain Tumor
- Recurrent Brain Tumors
Malignant Primary Brain Tumors- Malignant Primary Brain Tumors
- Primary Malignant Brain Tumors
- Malignant Primary Brain Neoplasms
- Primary Malignant Brain Neoplasms
- Brain Neoplasms, Malignant, Primary
- Brain Neoplasms, Primary Malignant
Benign Neoplasms, Brain- Benign Neoplasms, Brain
- Benign Neoplasm, Brain
- Brain Benign Neoplasm
- Brain Benign Neoplasms
- Neoplasms, Brain, Benign
- Brain Neoplasms, Benign
- Benign Brain Neoplasm
- Benign Brain Neoplasms
- Brain Neoplasm, Benign
Brain Tumor, Primary- Brain Tumor, Primary
- Brain Tumors, Primary
- Primary Brain Tumor
- Primary Brain Tumors
- Neoplasms, Brain, Primary
- Brain Neoplasm, Primary
- Brain Neoplasms, Primary
- Primary Brain Neoplasm
- Primary Brain Neoplasms
|
Below are MeSH descriptors whose meaning is more general than "Brain Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Brain Neoplasms".
This graph shows the total number of publications written about "Brain Neoplasms" by people in this website by year, and whether "Brain Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 2 | 1 | 3 | | 1992 | 8 | 0 | 8 | | 1993 | 10 | 1 | 11 | | 1994 | 6 | 0 | 6 | | 1995 | 7 | 1 | 8 | | 1996 | 8 | 2 | 10 | | 1997 | 12 | 0 | 12 | | 1998 | 8 | 3 | 11 | | 1999 | 9 | 2 | 11 | | 2000 | 9 | 1 | 10 | | 2001 | 5 | 2 | 7 | | 2002 | 5 | 1 | 6 | | 2003 | 16 | 2 | 18 | | 2004 | 7 | 2 | 9 | | 2005 | 5 | 2 | 7 | | 2006 | 13 | 1 | 14 | | 2007 | 9 | 1 | 10 | | 2008 | 11 | 1 | 12 | | 2009 | 25 | 1 | 26 | | 2010 | 21 | 1 | 22 | | 2011 | 9 | 1 | 10 | | 2012 | 16 | 4 | 20 | | 2013 | 21 | 2 | 23 | | 2014 | 27 | 4 | 31 | | 2015 | 27 | 2 | 29 | | 2016 | 22 | 3 | 25 | | 2017 | 21 | 5 | 26 | | 2018 | 25 | 3 | 28 | | 2019 | 37 | 5 | 42 | | 2020 | 22 | 1 | 23 | | 2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Brain Neoplasms" by people in Profiles.
-
Dahl NA, Vibhakar R. Converging evidence for inhibition of transcriptional control in high-grade gliomas. Neuro Oncol. 2021 08 02; 23(8):1225-1227.
-
Nieder C, Mehta MP, Guckenberger M, Gaspar LE, Rusthoven CG, Sahgal A, Grosu AL, De Ruysscher D. Assessment of extracranial metastatic disease in patients with brain metastases: How much effort is needed in the context of evolving survival prediction models? Radiother Oncol. 2021 06; 159:17-20.
-
Cloughesy TF, Petrecca K, Walbert T, Butowski N, Salacz M, Perry J, Damek D, Bota D, Bettegowda C, Zhu JJ, Iwamoto F, Placantonakis D, Kim L, Elder B, Kaptain G, Cachia D, Moshel Y, Brem S, Piccioni D, Landolfi J, Chen CC, Gruber H, Rao AR, Hogan D, Accomando W, Ostertag D, Montellano TT, Kheoh T, Kabbinavar F, Vogelbaum MA. Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma: A Randomized Clinical Trial. JAMA Oncol. 2020 12 01; 6(12):1939-1946.
-
Wright KD, Yao X, London WB, Kao PC, Gore L, Hunger S, Geyer R, Cohen KJ, Allen JC, Katzenstein HM, Smith A, Boklan J, Nazemi K, Trippett T, Karajannis M, Herzog C, Destefano J, Direnzo J, Pietrantonio J, Greenspan L, Cassidy D, Schissel D, Perentesis J, Basu M, Mizuno T, Vinks AA, Prabhu SP, Chi SN, Kieran MW. A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma. Pediatr Blood Cancer. 2021 02; 68(2):e28787.
-
Whiteway SL, Betts AM, O'Neil ER, Green AL, Gilani A, Orr BA, Mathis DA. Oncogenic GOPC-ROS1 Fusion Identified in a Congenital Glioblastoma Case. J Pediatr Hematol Oncol. 2020 11; 42(8):e813-e818.
-
Prince EW, Whelan R, Mirsky DM, Stence N, Staulcup S, Klimo P, Anderson RCE, Niazi TN, Grant G, Souweidane M, Johnston JM, Jackson EM, Limbrick DD, Smith A, Drapeau A, Chern JJ, Kilburn L, Ginn K, Naftel R, Dudley R, Tyler-Kabara E, Jallo G, Handler MH, Jones K, Donson AM, Foreman NK, Hankinson TC. Robust deep learning classification of adamantinomatous craniopharyngioma from limited preoperative radiographic images. Sci Rep. 2020 10 09; 10(1):16885.
-
Feliciano JT, Salmi L, Blotner C, Hayden A, Nduom EK, Kwan BM, Katz MS, Claus EB. Brain Tumor Discussions on Twitter (#BTSM): Social Network Analysis. J Med Internet Res. 2020 10 08; 22(10):e22005.
-
Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, Nesbit E, Kruser TJ, Chan J, Braunstein S, Lee J, Kirkpatrick JP, Breen W, Brown PD, Shi D, Shih HA, Soliman H, Sahgal A, Shanley R, Sperduto W, Lou E, Everett A, Boggs DH, Masucci L, Roberge D, Remick J, Plichta K, Buatti JM, Jain S, Gaspar LE, Wu CC, Wang TJC, Bryant J, Chuong M, Yu J, Chiang V, Nakano T, Aoyama H, Mehta MP. Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival. Neuro Oncol. 2020 09 29; 22(9):1359-1367.
-
Weaver MJ, Stump S, Campbell MJ, Backos DS, Li C, Reigan P, Adams E, Beall HD, Natale NR. 10-N-heterocylic aryl-isoxazole-amides (AIMs) have robust anti-tumor activity against breast and brain cancer cell lines and useful fluorescence properties. Bioorg Med Chem. 2020 11 15; 28(22):115781.
-
Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, Nesbit E, Kruser TJ, Chan J, Braunstein S, Lee J, Kirkpatrick JP, Breen W, Brown PD, Shi D, Shih HA, Soliman H, Sahgal A, Shanley R, Sperduto WA, Lou E, Everett A, Boggs DH, Masucci L, Roberge D, Remick J, Plichta K, Buatti JM, Jain S, Gaspar LE, Wu CC, Wang TJC, Bryant J, Chuong M, An Y, Chiang V, Nakano T, Aoyama H, Mehta MP. Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient. J Clin Oncol. 2020 11 10; 38(32):3773-3784.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|